Gilead Sciences, Inc.
Holdings as of Mar 31, 2026 · filed May 8, 2026
| # | Holding | Value | % Port. | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Arcellx Inc | $771682600 | 36.44% | — | Held |
| 2 | Arcus Biosciences Inc | $678774816 | 32.05% | — | Held |
| 3 | Galapagos Nv | $501224310 | 23.67% | — | Held |
| 4 | Assembly Biosciences Inc | $125024600 | 5.90% | — | Held |
| 5 | Kyverna Therapeutics Inc | $35608407 | 1.68% | — | Held |
| 6 | Xilio Therapeutics Inc | $5469771 | 0.26% | -8455062 | -92.86% |
Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.